← brief for 2026-09-22 · Slowing decline

Application of a Kidney Hierarchical Composite Endpoints in Trials of CKD Progression: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

Paper No results yet Peer reviewed

Key takeaways

This is a workshop report from the National Kidney Foundation, not a study, so there are no results. Experts discussed a new way to score drug trials for chronic kidney disease (CKD). This method ranks several outcomes by how much they matter, from death and kidney failure down to smaller changes. The goal is faster, more efficient trials, because many people still lose kidney function even on today's approved drugs.

Source

Paper · AJKD · 2026-09-22
https://www.ajkd.org/article/S0272-6386(26)01123-6/fulltext?rss=yes